173 related articles for article (PubMed ID: 1901909)
1. Influence of hypobaric hypoxia in infancy on the subsequent development of vasoconstrictive pulmonary vascular disease in the Wistar albino rat.
Caslin A; Heath D; Smith P
J Pathol; 1991 Feb; 163(2):133-41. PubMed ID: 1901909
[TBL] [Abstract][Full Text] [Related]
2. Failure to show decrease in small pulmonary blood vessels in rats with experimental pulmonary hypertension.
Kay JM; Suyama KL; Keane PM
Thorax; 1982 Dec; 37(12):927-30. PubMed ID: 6820578
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension induced in rats by monocrotaline and chronic hypoxia is reduced by p-chlorophenylalanine.
Kay JM; Keane PM; Suyama KL
Respiration; 1985; 47(1):48-56. PubMed ID: 3156395
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
van Suylen RJ; Smits JF; Daemen MJ
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
Kay JM; Keane PM; Suyama KL; Gauthier D
Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary, vascular responses in rats exposed to chronic hypobaric hypoxia at two different altitude levels.
Nakanishi K; Tajima F; Osada H; Nakamura A; Yagura S; Kawai T; Suzuki M; Torikata C
Pathol Res Pract; 1996 Oct; 192(10):1057-67. PubMed ID: 8958556
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
Mathew R; Gloster ES; Altura BT; Altura BM
Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural differences between pulmonary arteriolar muscularization induced by hypoxia and monocrotaline.
King A; Smith P; Heath D
Exp Mol Pathol; 1994 Aug; 61(1):24-35. PubMed ID: 7995377
[TBL] [Abstract][Full Text] [Related]
9. Effect of verapamil on monocrotaline-induced pulmonary artery hypertension and endothelial cell dysfunction in rats.
Mathew R; Guzowski DE; Gloster ES
Exp Lung Res; 1990; 16(6):627-44. PubMed ID: 1964410
[TBL] [Abstract][Full Text] [Related]
10. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.
Hislop A; Reid L
Br J Exp Pathol; 1976 Oct; 57(5):542-54. PubMed ID: 136978
[TBL] [Abstract][Full Text] [Related]
11. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.
Mitani Y; Maruyama K; Sakurai M
Circulation; 1997 Jul; 96(2):689-97. PubMed ID: 9244244
[TBL] [Abstract][Full Text] [Related]
12. [Effects of an extract of salviae miltiorrhizae (764-3) on structural remodeling of intra-acinar pulmonary artery in pulmonary hypertension due to chronic hypoxia and monocrotaline in rats].
Liu Z; Cheng X; Cai R
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jun; 21(6):358-60. PubMed ID: 11326894
[TBL] [Abstract][Full Text] [Related]
13. Changes in pulmonary structure and function induced by monocrotaline intoxication.
Ghodsi F; Will JA
Am J Physiol; 1981 Feb; 240(2):H149-55. PubMed ID: 6451183
[TBL] [Abstract][Full Text] [Related]
14. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
Orlinska U; Olson JW; Gillespie MN
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
[TBL] [Abstract][Full Text] [Related]
15. SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats.
Ilkiw R; Todorovich-Hunter L; Maruyama K; Shin J; Rabinovitch M
Circ Res; 1989 Apr; 64(4):814-25. PubMed ID: 2495195
[TBL] [Abstract][Full Text] [Related]
16. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.
Rosenberg HC; Rabinovitch M
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1484-91. PubMed ID: 3144186
[TBL] [Abstract][Full Text] [Related]
17. Supplemental oxygen reduces right ventricular hypertrophy in monocrotaline-injected rats.
Hill NS; Jederlinic P; Gagnon J
J Appl Physiol (1985); 1989 Apr; 66(4):1642-8. PubMed ID: 2525121
[TBL] [Abstract][Full Text] [Related]
18. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary toxicity of monocrotaline differs at critical periods of lung development.
Todd L; Mullen M; Olley PM; Rabinovitch M
Pediatr Res; 1985 Jul; 19(7):731-7. PubMed ID: 3161000
[TBL] [Abstract][Full Text] [Related]
20. Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity.
Maruyama K; Ye CL; Woo M; Venkatacharya H; Lines LD; Silver MM; Rabinovitch M
Am J Physiol; 1991 Dec; 261(6 Pt 2):H1716-26. PubMed ID: 1836309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
